This compound is an antiviral pharmaceutical raw material supplied for manufacturing purposes. It consists of a tenofovir alafenamide-like prodrug moiety and fumaric acid forming a salt-like, multi-component structure.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1432630-26-6
({[(Propan-2-yl)oxy]carbonyl}oxy)methyl hydrogen ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate
pharmaceutical intermediate
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-, bis(1-methylethyl) ester, 5-oxide
pharmaceutical intermediate
Lamivudine salicylate
pharmaceutical raw material
Maribavir
pharmaceutical raw material
Baloxavir
pharmaceutical raw material
Favipiravir
pharmaceutical raw material
Eletriptan
active pharmaceutical ingredient
Naratriptan hydrochloride
pharmaceutical raw material
[[(2S)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;(E)-but-2-enedioic acid
VCMJCVGFSROFHV-KZHAMYRLSA-N
C[C@@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C(=C/C(=O)O)\C(=O)O